Capitolis Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Capitolis Advisors LLC

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$187.49 - $221.1 $767,959 - $905,625
-4,096 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$207.02 - $241.31 $2.29 Million - $2.67 Million
-11,080 Reduced 73.01%
4,096 $880,000
Q4 2020

May 07, 2021
BUY
$207.01 - $276.09 $3.14 Million - $4.19 Million
15,176 New
15,176 $3.59 Million

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Capitolis Advisors LLC Portfolio

Follow Capitolis Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capitolis Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email